GRP
NAMS icon

Global Retirement Partners’s NewAmsterdam Pharma NAMS Stock Holding History

Global Retirement Partners’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$9.47K Buy
+270
New +$9.83K ﹤0.01% 3178
2024
Q4 		– Sell
-91
Closed -$1.51K – 3742
2024
Q3 		$1.51K Sell
91
-302
-77% -$5.22K ﹤0.01% 3030
2024
Q2 		$7.55K Buy
+393
New +$7.88K ﹤0.01% 2437

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Global Retirement Partners's NAMS Position: Q4 2025 in Review

Global Retirement Partners opened a new position in NewAmsterdam Pharma (NAMS) in Q4 2025: 270 shares worth $9.47K. The stake represents ﹤0.01% of the portfolio and ranks #3178 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in NAMS as recently as Q3 2024.

Global Retirement Partners first reported a position in NAMS in Q2 2024 and has held it in 3 quarters since. 186 funds tracked by Wall St. Rank hold NAMS as of Q4 2025.

  • Global Retirement Partners held 270 shares of NewAmsterdam Pharma worth $9.47K as of Q4 2025.
  • NewAmsterdam Pharma was a new Global Retirement Partners position in Q4 2025.
  • NewAmsterdam Pharma made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3178 holding.
  • Global Retirement Partners first reported a position in NewAmsterdam Pharma in Q2 2024 and has held it in 3 quarters since.
  • 186 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.